CClinicalTrials.gg
Status unknownNCT05637385Updated Dec 5, 2022

Training Oculo-motor Control to Improve Vision When Using a Preferred Retinal Locus

An interventional study of Training of perception and oculo-motor control in Central Visual Impairment, sponsored by Russell L. Woods. Status unknown. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-05.

Sponsored by Russell L. Woods · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

When high-detail vision is lost due to a retinal disease such as macular degeneration, people see poorly, and have difficulty with eye movements (oculo-motor control). This preliminary study will investigate a potential behavioral intervention that may improve the ability to perform vision-related daily activities such as reading, recognising faces and watching television. The intervention involves many sessions that will train visual perception and eye movements over a period of a few months. Participants will have either lost central vision in both eyes or have normal vision (control group).

Read the detailed description

The purpose of the study is evaluate a potential treatment for loss of (foveal) central vision in both eyes which results in the use of a preferred retinal locus (PRL). The treatment is a series of 16 sessions of about one-hour duration that will involve a mixture of oculomotor control (OMC) training, perceptual training, and scotoma awareness. Two groups will receive the training: (1) central vision loss; and (2) normal sight who will use a simulated scotoma (called control group below).

A single-site, two-way mixed factor, one within-subject and one between-subject, minimal-risk phase-2 study. Each participant with vision loss or in the control group will attend for three outcome-measurement visits and 16 training visits over a period of about two months (at 2 visits per week). Feasibility metrics will be obtained during recruitment and study conduct. PRL and OMC metrics will be obtained at every visit. Outcome metrics will be obtained before treatment, following 8 training sessions, and following 16 training sessions.

Participants in the control group will experience a simulated central scotoma created by a gaze-contingent visual display system that simulates the loss of central vision by obscuring a region of central vision during testing and training.

Participants will be trained using an integrated oculo-motor and perceptual training approach using a gaze-contingent visual display to provide scotoma awareness. Two tasks will alternate: (1) a textured search target that suddenly shifts, drifts smoothly, or is stable, requiring the subject to make a saccade, a smooth pursuit, or fixate, respectively, following which there is a same-different task to test attention; and (2) target following and visual search for (a) face within distractors, (b) object recognition and location, and (c) word recognition and object identification over cluttered background. During training, for the vision-loss group, the binocular scotoma (created by the retinal lesions) will be outlined using a gaze-contingent system, so that the subject will see a border at the edge of their binocular scotoma that moves with gaze, alerting them to the location of the scotoma.

In addition to the 16 training sessions, there will be longer (2.5 to 3 hours) measurement sessions: (1) before training; (2) after 8 training sessions; and (3) after 16 training sessions. Due to the number of procedures, the first measurement session might consist of two sessions. Thus, each participant with vision loss will participate in 19 or 20 sessions in total.

Ideally, participants will attend for two visits per week. However, the schedule is flexible and can be adapted to a participants schedule.

02

Conditions studied

  • Central Visual Impairment
03

In context

Vision Disorders

308 studies on the registry are indexed under Vision Disorders; 81 are open to participants now.

This study's planned enrollment of 24 is below the median of 66 across 211 interventional studies indexed under Vision Disorders.

Browse Vision Disorders studies →

Lead sponsor

This is the only study on the registry with Russell L. Woods as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Central Vision Loss Group

Inclusion Criteria:

  • Bilateral foveal loss that includes the fovea in each eye, as determined through retinal examination
  • fluent in English
  • Cognitive function MoCA (Montreal Cognitive Assessment) test >20
  • Binocular visual acuity 20/800 or better
  • able to sit for at least an hour

Exclusion Criteria:

  • speech impediment
  • history of neurological or psychiatric disease
  • inability to provide informed consent
  • inability to follow instructions in English

Normal Vision Control Group

Inclusion Criteria:

  • fluent in English
  • Cognitive function MoCA (Montreal Cognitive Assessment) test >25
  • Binocular visual acuity 20/40 or better
  • able to sit for at least an hour

Exclusion Criteria:

  • any ophthalmic disease that might impact on the conduct of the study, especially conditions that cause vision field loss
  • speech impediment
  • history of neurological or psychiatric disease
  • inability to provide informed consent
  • inability to follow instructions in English
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    central vision loss

    will receive behavioral intervention

    Behavioral: Training of perception and oculo-motor control

  • Active comparator
    normal vision

    using simulated central scotomas, will receive behavioral intervention

    Behavioral: Training of perception and oculo-motor control

Interventions

  • BehavioralTraining of perception and oculo-motor control

    Behavioral training of eye movements and perception

06

What researchers measure

Primary outcomes

  1. reading speed following eight training sessions

    reading of paragraphs of text

    Time frame: comparing reading speed before intervention and after 8 sessions of training

  2. reading speed following sixteen training sessions

    reading of paragraphs of text

    Time frame: comparing reading speed before intervention and after 16 sessions of training

  3. face discrimination threshold following eight training sessions

    recognizing differences between faces

    Time frame: comparing face discrimination thresholds before intervention and after 8 sessions of training

  4. face discrimination threshold following sixteen training sessions

    recognizing differences between faces

    Time frame: comparing face discrimination thresholds before intervention and after 16 sessions of training

  5. video comprehension (shared word score) following eight training sessions

    understanding and describing the content of short video clips

    Time frame: comparing shared word scores before intervention and after 8 sessions of training

  6. video comprehension (shared word score) following sixteen training sessions

    understanding and describing the content of short video clips

    Time frame: comparing shared word scores before intervention and after 16 sessions of training

Secondary outcomes

  1. PRL location relative to the location before the intervention (training)

    location of the preferred retinal locus measured from a retinal image obtained during a fixation examination

    Time frame: location at each of the 16 training sessions as compared to the location before intervention

  2. Oculo-motor reference location relative to the location before the intervention (training)

    first landing location of saccades to a new location measured using a gaze tracking system; measures whether there has been an adjustment of eye movement planning

    Time frame: at each of the 16 training sessions as compared to the location before intervention

  3. saccade dynamics relative to the location before the intervention (training)

    slope of the saccadic main sequence, which is the speed to distance relationship of saccades (fast eye movements), as measured using a gaze tracking system

    Time frame: at each of the 16 training sessions as compared to the location before intervention

  4. single-letter visual acuity following eight training sessions

    ability to read single letters of varying size

    Time frame: comparing visual acuity before intervention and after 8 sessions of training

  5. single-letter visual acuity following sixteen training sessions

    ability to read single letters of varying size

    Time frame: comparing visual acuity before intervention and after 16 sessions of training

  6. letter contrast sensitivity following eight training sessions

    ability to read "large" letters of low contrast

    Time frame: comparing letter contrast sensitivity before intervention and after 8 sessions of training

  7. letter contrast sensitivity following sixteen training sessions

    ability to read "large" letters of low contrast

    Time frame: comparing letter contrast sensitivity before intervention and after 16 sessions of training

  8. Geriatric Depression Scale (GDS) following eight training sessions

    evaluate depression and aspects of quality of life

    Time frame: comparing GDS scores before intervention and after 8 sessions of training

  9. Geriatric Depression Scale (GDS) following sixteen training sessions

    evaluate depression and aspects of quality of life

    Time frame: comparing GDS scores before intervention and after 16 sessions of training

  10. Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ) following eight training sessions

    measure of visual ability and vision-related limitations

    Time frame: comparing VA LV VFQ scores before intervention and after 8 sessions of training

  11. Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ) following sixteen training sessions

    measure of visual ability and vision-related limitations

    Time frame: comparing VA LV VFQ scores before intervention and after 16 sessions of training

Other outcomes

  1. enrollment rate

    compares the number of participants who enroll in the study to the number of potential participants identified; and the time taken to enroll the study sample, and reasons for lack of willingness to participate (qualitative)

    Time frame: duration of enrollment period

  2. retention rate

    compares the number of participants who complete the study to the number of participants who enrolled in the study; and obtain reasons for dropout

    Time frame: duration of intervention period

  3. treatment fidelity

    adherence to the treatment session schedule, the adherence rate, any adherence pattern, and reasons for adherence failures

    Time frame: duration of intervention period

  4. measurement fidelity

    ability to obtain outcome measures (proportion of outcome measures completed, period and variance of improvement across subjects), obtain feedback on acceptability of outcome measures, and qualitative reasons for failure to complete specific outcome measures.

    Time frame: duration of intervention period

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — If approved by our IRB (Institutional Review Board), we may be able to share de-identified outcome metrics and eye movement measurements. A data use agreement would be required.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05637385
Lead sponsor
Russell L. Woods
Collaborators
Research to Prevent Blindness / Lions Club International Foundation
Responsible party
Russell L. Woods (Associate Scientist, Schepens Eye Research Institute) — Sponsor-investigator
First posted
Dec 5, 2022
Start date
Mar 1, 2023 (estimated)
Primary completion
Oct 1, 2024 (estimated)
Completion
Oct 1, 2024 (estimated)
Last update
Dec 5, 2022

Study contacts

Zoe E Roth, BME
Contact
zroth@meei.harvard.edu
617 912 2590
Russell L Woods, PhD
principal investigator · Schepens Eye Research Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion